SCHEMBL27875845

SCHEMBL27875845

[CH2]CCc1ccc(Cl)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
SIGMAR1 Q99720 6/20 0.37
CYP1A2 P05177 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
S1PR1 P21453 1/20 0.36
SKP2 Q13309 1/20 0.36
CYP2D6 P10635 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
MCL1 Q07820 1/20 0.36
IDO1 P14902 3/20 0.35
IGF1R P08069 1/20 0.35
ALOX15 P16050 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.35
PTPN7 P35236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753927 0.83 S1PR1 (0.38) PNMTTAAR1MEN1KMT2AS1PR1
SCHEMBL12841593 0.81 SKP2 (0.46) PNMTTAAR1SIGMAR1CYP1A2MEN1
SCHEMBL1612361 0.80 SKP2 (0.39) CYP1A2ALDH1A1MAPTCYP2C19SKP2
SCHEMBL3565937 0.80 PNMT (0.61) PNMTTAAR1SIGMAR1CYP1A2MEN1
SCHEMBL29434783 0.79 ALDH1A1 (0.47) PNMTTAAR1ALDH1A1TP53MAPT
SCHEMBL12333663 0.79 ALDH1A1 (0.47) PNMTTAAR1ALDH1A1TP53MAPT
SCHEMBL7458179 0.79 PNMT (0.41) PNMTTAAR1SIGMAR1CYP1A2MEN1
SCHEMBL3840980 0.79 TAAR1 (0.67) PNMTTAAR1SIGMAR1CYP1A2ALDH1A1
SCHEMBL86433 0.76 SKP2 (0.42) PNMTTAAR1SIGMAR1CYP1A2MEN1
SCHEMBL81132 0.76 IGF1R (0.44) PNMTTAAR1ALDH1A1TP53S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102741227-A Aryl benzylamine compounds NOVARTIS AG 2012-10-17 CN claimed
CN-102741227-A Aryl benzylamine compounds NOVARTIS AG 2012-10-17 CN disclosed